Cargando…
Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy
Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a pleiotropic protein, promoting both tumor-suppressive and tumor-promoting activities. While TIMP-1 is primarily known as an endogenous inhibitor of matrix metalloproteinases (MMPs) and thus associated with tumor cell invasion, clinical studies d...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005868/ https://www.ncbi.nlm.nih.gov/pubmed/32034211 http://dx.doi.org/10.1038/s41598-020-58964-x |
_version_ | 1783495026741870592 |
---|---|
author | Warner, Richard B. Najy, Abdo J. Jung, Young Suk Fridman, Rafael Kim, Seongho Kim, Hyeong-Reh Choi |
author_facet | Warner, Richard B. Najy, Abdo J. Jung, Young Suk Fridman, Rafael Kim, Seongho Kim, Hyeong-Reh Choi |
author_sort | Warner, Richard B. |
collection | PubMed |
description | Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a pleiotropic protein, promoting both tumor-suppressive and tumor-promoting activities. While TIMP-1 is primarily known as an endogenous inhibitor of matrix metalloproteinases (MMPs) and thus associated with tumor cell invasion, clinical studies demonstrated increased expression of TIMP-1 and its association with poor prognosis in cancer. Non-MMP-inhibitory and oncogenic functions of TIMP-1 are mediated by induction of intracellular signaling via its cell surface receptor CD63, a tetraspanin. The present study investigates the structure-function relationship of TIMP-1 for its interaction with CD63, which may eventually help design a novel approach for targeting TIMP-1’s pro-oncogenic activity without interfering its tumor suppressive MMP-inhibitory function. Importantly, our analysis includes TIMP-1/CD63 interactions at the cell surface of live cells. Here, we demonstrate that the 9 C-terminal amino acid residues of TIMP-1 and the large extracellular loop of CD63 are required for their interaction. Considering that the N-terminal half of TIMP-1 is sufficient for TIMP-1’s MMP-inhibitory activity, we propose that those C-terminal amino acid residues are a potentially targetable motif of TIMP-1 oncogenic activity. As a proof of concept, we present the potential for the development of neutralizing antibodies against the C-terminal motif of TIMP-1 for disruption of TIMP-1 interaction with CD63 and the subsequent signal transduction. |
format | Online Article Text |
id | pubmed-7005868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70058682020-02-18 Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy Warner, Richard B. Najy, Abdo J. Jung, Young Suk Fridman, Rafael Kim, Seongho Kim, Hyeong-Reh Choi Sci Rep Article Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a pleiotropic protein, promoting both tumor-suppressive and tumor-promoting activities. While TIMP-1 is primarily known as an endogenous inhibitor of matrix metalloproteinases (MMPs) and thus associated with tumor cell invasion, clinical studies demonstrated increased expression of TIMP-1 and its association with poor prognosis in cancer. Non-MMP-inhibitory and oncogenic functions of TIMP-1 are mediated by induction of intracellular signaling via its cell surface receptor CD63, a tetraspanin. The present study investigates the structure-function relationship of TIMP-1 for its interaction with CD63, which may eventually help design a novel approach for targeting TIMP-1’s pro-oncogenic activity without interfering its tumor suppressive MMP-inhibitory function. Importantly, our analysis includes TIMP-1/CD63 interactions at the cell surface of live cells. Here, we demonstrate that the 9 C-terminal amino acid residues of TIMP-1 and the large extracellular loop of CD63 are required for their interaction. Considering that the N-terminal half of TIMP-1 is sufficient for TIMP-1’s MMP-inhibitory activity, we propose that those C-terminal amino acid residues are a potentially targetable motif of TIMP-1 oncogenic activity. As a proof of concept, we present the potential for the development of neutralizing antibodies against the C-terminal motif of TIMP-1 for disruption of TIMP-1 interaction with CD63 and the subsequent signal transduction. Nature Publishing Group UK 2020-02-07 /pmc/articles/PMC7005868/ /pubmed/32034211 http://dx.doi.org/10.1038/s41598-020-58964-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Warner, Richard B. Najy, Abdo J. Jung, Young Suk Fridman, Rafael Kim, Seongho Kim, Hyeong-Reh Choi Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy |
title | Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy |
title_full | Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy |
title_fullStr | Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy |
title_full_unstemmed | Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy |
title_short | Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy |
title_sort | establishment of structure-function relationship of tissue inhibitor of metalloproteinase-1 for its interaction with cd63: implication for cancer therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005868/ https://www.ncbi.nlm.nih.gov/pubmed/32034211 http://dx.doi.org/10.1038/s41598-020-58964-x |
work_keys_str_mv | AT warnerrichardb establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy AT najyabdoj establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy AT jungyoungsuk establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy AT fridmanrafael establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy AT kimseongho establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy AT kimhyeongrehchoi establishmentofstructurefunctionrelationshipoftissueinhibitorofmetalloproteinase1foritsinteractionwithcd63implicationforcancertherapy |